AL Nasamat General Trading CO. Pharmaceutical Import Profile — United Arab Emirates (DGFT 2022–2026)

Name: AL Nasamat General Trading CO. Pharmaceutical Import Records from India — 3 Products, $156.9K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

AL Nasamat General Trading CO. — Pharmaceutical Importer Profile (2026) | 3 Products, $156.9K Trade | TransData Nexus

AL Nasamat General Trading CO.

Pharmaceutical Importer · United Arab Emirates · Ayurvedic & Herbal Products Focus · $156.9K Total Trade · DGFT Verified

AL Nasamat General Trading CO. is a pharmaceutical importer based in United Arab Emirates with a total trade value of $156.9K across 3 products in 1 therapeutic categories. Based on 270 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. AL Nasamat General Trading CO. sources from 11 verified Indian suppliers, with Sree Exports accounting for 71.2% of imports.

AL Nasamat General Trading CO. — Import Portfolio & Supplier Network

AL Nasamat General Trading CO. import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to AL Nasamat General Trading CO.?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Sree Exports	$418.8K	1,719	71.2%
J And J Kalan Pharmacy Private Limited	$58.2K	36	9.9%
Kairali Exports	$34.3K	382

What Formulations Does AL Nasamat General Trading CO. Import?

Formulation	Value	Ships
Ayurvedic products :murivenna ( 200ML )	$18.8K	3
Ayurvedic products :murivenna ( 200ML )	$15.8K	3
Ayurvedic products :karpuradi tailam ( 200ML )	$10.6K	3
Ayurvedic products :murivenna ( 200ML	$7.5K	1
75 ctns neelibringadi coconut oil 200ML	$7.0K	2
Ayurvedic products :karpuradi tailam ( 200ML	$6.7K	1
Ayurvedic products :karpuradi tailam ( 200ML )	$4.9K	2
52 ctns neelibringadi gingely oil 200ML	$4.8K	2
25 ctns kesamrutham - 100	$4.6K	2
Ayurvedic products :dhanwantaram tailam( 200ML )	$4.5K	2
Krishna thulsi syp 100ML	$4.3K	1
50 ctns kesamrutham 200	$4.2K	1
Ayurvedic products :karpuradi tailam	$4.2K	1
Ayurvedic products :karpuradi tailam	$4.1K	2
Eladi lehyam 100GM x 72	$4.0K	3

AL Nasamat General Trading CO. imports 1,742 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Taila	Ayurvedic & Herbal Products	$137.4K	189	1.1%	11
2	Arishta	Ayurvedic & Herbal Products	$13.4K	44	0.9%	16
3	Ghrita	Ayurvedic & Herbal Products	$6.1K	37	0.7%	9

AL Nasamat General Trading CO. imports 3 pharmaceutical products across 1 categories into United Arab Emirates totaling $156.9K.

AL Nasamat General Trading CO. — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Al Nasamat General Trading Co. LLC, established in 1976, is a Dubai-based company specializing in the import and distribution of Ayurvedic and herbal pharmaceutical products. The company operates as a pharmaceutical importer and buyer, focusing on finished pharmaceutical formulations such as tablets, capsules, syrups, and injections. Headquartered in Deira, Dubai, Al Nasamat General Trading Co. LLC has been a significant player in the UAE's pharmaceutical distribution network for over four decades. The company's portfolio includes a range of products from well-known Indian manufacturers, catering to the growing demand for natural and herbal healthcare solutions in the UAE.

2Distribution Network

Al Nasamat General Trading Co. LLC's distribution network is centered in Dubai, with its main office located on Al Shamali Street, near the Gold Souq in Deira. The company operates a warehouse facility equipped to handle the storage and distribution of pharmaceutical products, ensuring compliance with UAE regulations for pharmaceutical storage and distribution. While specific details about additional warehouse locations or logistics capabilities are not publicly disclosed, the company's strategic location in Dubai positions it effectively to serve the UAE market and potentially extend its reach to other GCC and Middle East countries.

3Industry Role

Al Nasamat General Trading Co. LLC functions primarily as a pharmaceutical importer and distributor within the UAE's pharmaceutical supply chain. By sourcing finished pharmaceutical formulations from Indian manufacturers, the company plays a crucial role in introducing Ayurvedic and herbal products to the UAE market. Its focus on importing finished products indicates a strategic approach to meet the demand for ready-to-use pharmaceutical solutions, positioning the company as a key player in the distribution of natural and herbal healthcare products in the region.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — AL Nasamat General Trading CO.

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Al Nasamat General Trading Co. LLC's sourcing strategy exhibits a high degree of concentration, with the top five products accounting for 100% of its imports from India. This indicates a focused approach, potentially leveraging strong relationships with specific suppliers to ensure product quality and consistency. The company's reliance on a limited number of products may enhance operational efficiency but also exposes it to risks associated with supply chain disruptions or changes in supplier dynamics. The shipment data reveals a stable relationship with key suppliers, as evidenced by the consistent volume of imports over the years. However, the lack of diversification in product sourcing could be a strategic choice to maintain a specialized product line, catering to a niche market segment within the UAE's pharmaceutical industry.

2Supply Chain Resilience

Al Nasamat General Trading Co. LLC's supply chain resilience is closely tied to its sourcing strategy. The company's focus on a limited number of products from specific Indian suppliers suggests a streamlined supply chain, which can lead to cost efficiencies and stronger supplier relationships. However, this concentration also means that any disruptions with these suppliers—such as production delays, regulatory issues, or logistical challenges—could significantly impact the company's ability to meet market demand. The company's reliance on a single therapeutic category, Ayurvedic and Herbal Products, further underscores the importance of maintaining robust relationships with its suppliers to ensure a steady supply of products.

Importing Pharmaceuticals into United Arab Emirates — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United Arab Emirates

1Regulatory Authority & Framework

The United Arab Emirates' pharmaceutical sector is regulated by the Ministry of Health and Prevention (MOHAP), which oversees the import, registration, and distribution of pharmaceutical products. The primary legislation governing this sector is Federal Law No. 14 of 1995, which addresses the importation of narcotic drugs and psychotropic substances. Additionally, Federal Law No. 17 of 2002 (Patent Law) and Ministry of Health Resolution No. 404 of 2000 (Patent Resolution) govern the registration of patents in pharmaceuticals. These regulations ensure that all pharmaceutical products, including those imported by companies like Al Nasamat General Trading Co. LLC, meet the required safety, efficacy, and quality standards before entering the UAE market.

2Import Licensing & GMP

To import pharmaceutical products into the UAE, companies must obtain a medical warehouse license issued by the Ministry of Health and Prevention (MOHAP). This license confirms that the company is authorized to import pharmaceutical or medical device products. The warehouse must meet specific requirements, including appropriate size, location, and equipment for pharmaceutical storage. Additionally, the warehouse must be managed by a licensed pharmacist. Regarding Good Manufacturing Practice (GMP) certification, the UAE recognizes certifications from reputable bodies such as the European Union (EU) GMP, World Health Organization (WHO) GMP, and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). These certifications ensure that imported pharmaceutical products meet international quality standards.

AL Nasamat General Trading CO. — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Al Nasamat General Trading Co. LLC's focus on Ayurvedic and herbal pharmaceutical products aligns with the growing consumer preference for natural and holistic healthcare solutions in the UAE. The demand for such products is driven by increasing health consciousness among consumers and a desire for alternatives to conventional medicine. By importing products from reputable Indian manufacturers, the company caters to this market demand, offering a range of products that emphasize natural ingredients and traditional healing practices. This strategic focus positions Al Nasamat General Trading Co. LLC as a key player in the niche market of Ayurvedic and herbal pharmaceuticals in the UAE.

2Sourcing Profile

Al Nasamat General Trading Co. LLC's sourcing strategy is centered on importing finished pharmaceutical formulations from Indian manufacturers. The company's focus on Ayurvedic and herbal products indicates a preference for natural and traditional formulations. India's well-established pharmaceutical industry, known for its adherence to international quality standards and GMP certifications, makes it an attractive sourcing destination for Al Nasamat General Trading Co. LLC. This sourcing approach allows the company to offer a diverse range of products that meet the specific needs of the UAE market.

3Market Positioning

Seller's Guide — How to Become a Supplier to AL Nasamat General Trading CO.

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the UAE market through partnerships with Al Nasamat General Trading Co. LLC. The company's established distribution network and focus on Ayurvedic and herbal products provide a platform for suppliers to reach a targeted consumer base. Potential suppliers should ensure their products meet the UAE's regulatory requirements, including GMP certifications and appropriate documentation, to facilitate a smooth entry into the market.

2Requirements & Qualifications

Indian exporters seeking to supply Al Nasamat General Trading Co. LLC and the UAE market must ensure their products are manufactured in facilities with recognized GMP certifications, such as EU GMP, WHO GMP, or PIC/S. Additionally, products must comply with UAE labeling requirements, including Arabic language labeling, and meet all regulatory standards set by the UAE Ministry of Health and Prevention. Providing comprehensive documentation, including Certificates of Analysis, stability data, and product dossiers

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — AL Nasamat General Trading CO.

What products does AL Nasamat General Trading CO. import from India?

AL Nasamat General Trading CO. imports 3 pharmaceutical products across 1 categories. Top imports: Taila ($137.4K), Arishta ($13.4K), Ghrita ($6.1K).

Who supplies pharmaceuticals to AL Nasamat General Trading CO. from India?

AL Nasamat General Trading CO. sources from 11 verified Indian suppliers. The primary supplier is Sree Exports (71.2% of imports, $418.8K).

What is AL Nasamat General Trading CO.'s total pharmaceutical import value?

AL Nasamat General Trading CO.'s total pharmaceutical import value from India is $156.9K, based on 270 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does AL Nasamat General Trading CO. focus on?

AL Nasamat General Trading CO. imports across 1 categories. The largest: Ayurvedic & Herbal Products (100.0%).

Get Full AL Nasamat General Trading CO. Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.